Related Experiment Videos
Nebulised beclomethasone dipropionate suspension.
Archives of Disease in Childhood
|November 1, 1986
Summary
Nebulized beclomethasone dipropionate suspension showed a trend toward improvement in children with asthma but was not significantly more effective than placebo. Further research is needed to compare its efficacy against other inhaled steroid formulations.
Area of Science:
- Pediatric Pulmonology
- Respiratory Medicine
- Clinical Pharmacology
Background:
- Asthma management in children requires effective topical steroid delivery.
- Nebulized formulations offer an alternative delivery route for asthma medications.
Purpose of the Study:
- To evaluate the efficacy of nebulized beclomethasone dipropionate suspension compared to placebo in children with moderately severe asthma.
Main Methods:
- A double-blind, crossover study design was employed.
- Sixteen children with moderately severe asthma participated.
- Patients received either nebulized beclomethasone dipropionate suspension or placebo.
Main Results:
- Eight out of thirteen children improved on beclomethasone, while five improved on placebo.
- Three children withdrew from the study due to worsening asthma symptoms during placebo treatment.
- The observed trends favoring nebulized beclomethasone were not statistically significant.
Conclusions:
- Nebulized beclomethasone dipropionate suspension demonstrated a potential benefit in pediatric asthma, but efficacy did not reach statistical significance.
- The study suggests that this suspension formulation may not be as effective as other inhaled corticosteroid options like powders or aerosols.